CYMEVENE (ganciclovir) administered as the IV in fusion is indicated for the palliative treatment of confirmed sight - threatening cytomegalovirus (CMV) disease in AIDS and other severely immunocompromised individuals. It is indicated for the treatment of confirmed CMV pneumonitis in bone marrow transplan t patients. It is also indicated for the prophylaxis of CMV infection and disease following bone marrow and solid organ transplantation in patients at risk of CMV disease.
NOTE: CYMEVENE (ganciclovir) is not indicated for congenital or neonatal CMV diseas e; nor for the treatment of CMV infection in non - immunocompromised individuals
Quote From www.roche-australia.com
Please contact +91 8130290915 for Cymevene 500 mg price in India
We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
IKRIS PHARMA NETWORK connects buyer with the supplier who can ship Cymevene 500 mg (Cancer Treatment Medicines) to any country of the world as per the buyer's requirement and Government regulations of the country. Cymevene 500 mg is manufactured by Roche Korea Co., Ltd.
IKRIS PHARMA NETWORK provides options of choosing exporter and supplier of Cancer treatment Medicines We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
Cymevene is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
IKRIS Pharma Network facilitates import of cancer medicines on the named patient supply. IKRIS Pharma Network is facilitator providing input
Cymevene can be made available Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune and other cities in India"
IKRIS Pharma Network can facilitate the supply of Cymevene (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)
The order will be confirmed only after the receipt of
Cost of Cymevene (ganciclovir) 500 mg in Australia, Brazil, China, Canada, Eqypt, Europe, France, Germany, Hongkong, India, Iran, Italy, Mexico, Pakistan, Poland, Spain, Singapore, Thailand, Russia, Romania, UK, Middle East, UAE, Ukraine.
General disclaimer under Facts and usage:
Please note that all information in relation to this drug is of general nature and may not be applicable to your specific situation and circumstance. Any information available here is not a substitute for professional medical advice by a licensed practitioner. We will help you in importing this medicine only upon the valid prescription of a licensed medical practitioner and other documents as required by the laws of the jurisdiction in which you are present.
General disclaimer under where can I buy the medicine/is the medicine available in India:
Please note that Ikris Pharma Network is a consultancy company, which facilitates patients, hospitals, clinicians and researchers in accessing products, which are not available or approved in their home country. Ikris Pharma Network has no relation whatsoever with this medicine including but not limited to being its manufacturer, seller, reseller, distributor, agent or licensee. Ikris Pharma will not purchase this medicine but will only assist you in doing so against a valid prescription and other documents as required by the laws of the jurisdiction in which you are present. None of the trademarks and other intellectual property and proprietary marks of this medicine belong to or are claimed to belong to the Ikris Pharma Network.